What do biotech companies need to consider as they develop the next breakthrough treatment for patients? Business leaders consider executive leadership, board development, and financing as priorities. There has been a shift in the industry allowing diversity, equity, and inclusion to inform these key drivers at organizations. For the third year, BIO, in partnership with Coqual, is launching the Measuring Diversity and Inclusion in Biotech report. Attend to get the newest data on DEI in the industry. Leaders will also discuss connecting the dots on how to implement best practices that drive success for delivering safe and effective medicines to communities and building inclusive companies.